Testing effectiveness (Phase 2)Ended earlyNCT01055067
What this trial is testing
ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors
Who this might be right for
Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas)
Daiichi Sankyo 27